Kamei A
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
Jpn J Ophthalmol. 1990;34(2):216-24.
The mechanism of lens protein aggregation with age and/or cataract formation was investigated using the peptides resolubilized from the insoluble protein fraction of normal and cataractous human lenses. The insoluble fraction was treated with reductants for cleaving disulfide bonds, or with chelating agents for removing calcium ions from the aggregates. This study demonstrates that the insoluble protein aggregates consist of an approximately 400 Kd complex, which is formed by the peptides with lower molecular weight. Protein aggregation in the cataractous lens might be caused by disulfide bonds whereas, in aging, the aggregate might be preferentially formed by calcium ion bridges rather than by disulfide bonds. It was observed that the aggregate from the cataractous lenses involved a peptide with a molecular mass lower by 1 Kd or 2 Kd than the peptides found in the normal lens. The composition of crystallins in aggregating proteins and their secondary structures were also different in the normal and the cataractous lenses. Such changes of molecular weight, conformation, and/or crystallin species in the lens may lead to the disintegration of the orderly arrangement of crystallins, resulting in the diffused reflection and lens opacities which are seen in senile cataract.
利用从正常和白内障患者晶状体不溶性蛋白组分中重新溶解的肽段,研究了晶状体蛋白随年龄增长和/或白内障形成的聚集机制。不溶性组分用还原剂处理以裂解二硫键,或用螯合剂从聚集体中去除钙离子。本研究表明,不溶性蛋白聚集体由一个约400 Kd的复合物组成,该复合物由较低分子量的肽段形成。白内障晶状体中的蛋白聚集可能由二硫键引起,而在衰老过程中,聚集体可能优先由钙离子桥而非二硫键形成。观察到白内障晶状体中的聚集体包含一种分子量比正常晶状体中发现的肽段低1 Kd或2 Kd的肽段。正常晶状体和白内障晶状体中聚集蛋白中的晶状体蛋白组成及其二级结构也不同。晶状体中分子量、构象和/或晶状体蛋白种类的这种变化可能导致晶状体蛋白有序排列的解体,从而导致在老年性白内障中可见的散射反射和晶状体混浊。